Infectologia

Anticorpos monoclonais contra raiva: usos atuais na profilaxia e na terapia.

22 Fev, 2022 | 15:00h

Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy – Current Opinion in Virology

---

Estudo randomizado | Em pacientes com Covid-19 leve a moderada e comorbidades, o tratamento com ivermectina não reduziu o risco de progressão da doença.

22 Fev, 2022 | 14:55h

Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial – JAMA Internal Medicine

Comentários:

Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN

Ivermectin futile for mild to moderate COVID-19, study finds – CIDRAP

Conteúdos relacionados:

Case Series: Toxic effects from ivermectin use associated with prevention and treatment of Covid-19.

Long-term consequences of the misuse of ivermectin data.

Ivermectin: How false science created a Covid ‘miracle’ drug.

Fraudulent ivermectin studies open up new battleground between science and misinformation.

The lesson of ivermectin: meta-analyses based on summary data alone are inherently unreliable.

Ivermectin: Cochrane’s most talked about review so far, ever. Why?

Flawed ivermectin preprint highlights challenges of COVID drug studies.

Systematic review: no evidence to support the use of Ivermectin for treating or preventing COVID-19.

Why was a major study on ivermectin for covid-19 just retracted?

RCT: Ivermectin does not prevent hospitalizations in patients with COVID-19.

Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials – “IVM did not reduce all-cause mortality, length of stay or viral clearance in RCTs in COVID-19 patients with mostly mild disease”.

Ivermectin is the new hydroxychloroquine, take 2 – “Ivermectin shouldn’t be used to treat COVID-19 outside of the context of a well-designed clinical trial”.

Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

RCT: Ivermectin does not improve time to resolution of symptoms among adults with mild COVID-19

---

Revisão da literatura e metanálise | Efetividade das vacinas contra COVID-19 no mundo real.

22 Fev, 2022 | 14:53h

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis – International Journal of Infectious Diseases

---

Diretrizes rápidas da ESCMID para avaliação e tratamento de “long COVID”.

22 Fev, 2022 | 14:52h

ESCMID rapid guidelines for assessment and management of long COVID – Clinical Microbiology and Infection

Conteúdos relacionados:

ERS statement on Long COVID-19 follow-up.

Proposed subtypes of long-Covid and their respective potential therapies.

EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.

Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.

Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.

Provocative study suggests that persistent physical symptoms after COVID-19 infection may be associated more with the belief in having been infected with SARS-CoV-2 than with having laboratory-confirmed COVID-19 infection.

Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.

Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.

WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).

Characterizing long COVID: a living systematic review.

Long Covid – The illness narratives.

New guidelines to help doctors manage long COVID patients published.

M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)

---

Revisão | “Long COVID”: sequelas pós-agudas de COVID-19 com foco cardiovascular.

22 Fev, 2022 | 14:49h

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus – European Heart Journal

Comunicado de imprensa: Review highlights impact of Long COVID on cardiovascular system – University of Oxford

Conteúdos relacionados:

The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.

COVID-19 infections increase risk of heart conditions up to a year later, study finds.

---

Perspectiva | É hora de conviver com a COVID-19? Alguns cientistas alertam para uma “ilusão endêmica”.

22 Fev, 2022 | 14:48h

Is it time to live with COVID-19? Some scientists warn of ‘endemic delusion’ – Science

---

Estudo randomizado | Dose única de metronidazol vs. tratamento de 7 dias para Trichomonas vaginalis em mulheres.

22 Fev, 2022 | 14:20h

A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women – Sexually Transmitted Diseases (link para o resumo – $ para o texto completo)

---

Liberado pelo Advisory Committee on Immunization Practices (ACIP) o novo calendário de imunização de adultos nos EUA.

19 Fev, 2022 | 14:12h

Recommended Adult Immunization Schedule, United States, 2022 – Annals of Internal Medicine

Comunicado de imprensa: New adult immunization schedule recommends changes to zoster, pneumococcal, and hep B vaccines – American College of Physicians

Ver também: Adult Immunization Schedule: Recommendations for Ages 19 Years or Older, United States, 2022 – Centers for Disease Control and Prevention

---

Liberado pelo Advisory Committee on Immunization Practices (ACIP) o novo calendário de imunização de crianças e adolescentes nos EUA.

19 Fev, 2022 | 14:10h

Recommended Childhood and Adolescent Immunization Schedule: United States, 2022 – Pediatrics

Ver também:

Child and Adolescent Immunization Schedule: Recommendations for Ages 18 Years or Younger, United States, 2022 – Centers for Disease Control and Prevention

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022 – CDC Morbidity and Mortality Weekly Report

---

Estudo de coorte | Riscos de desfechos de saúde mental em pessoas com Covid-19.

19 Fev, 2022 | 14:08h

Risks of mental health outcomes in people with covid-19: cohort study – The BMJ

Editorial: Mental health after covid-19 – The BMJ

Comunicado de imprensa: Study suggests increased risk of mental health disorders after COVID-19 infection – BMJ

Comentários:

Mental health in people with covid-19 – The BMJ

Large study reveals clearer links between COVID-19, mental health risks – CIDRAP

---